Objective To investigate the clinical effect of composite rennet capsules in the treatment of children diarrhea.Methods 108 cases of pediatric patients with diarrhea since from March 2012 to April 2013 were chosen as the research object. According to the order label children admitted to hospital, the even array was as the observation group, and the odd was as the control group, and 54 cases in each group. The observation group was taken with orally composite rennet capsules, and the control group was taken with conventional anti-inflammatory drug therapy. The course was treated for three weeks. The two groups were followed up every week. The clinical symptoms and the clinical total efficiency rate of the two groups were compared.Results After treatment, symptom scores decreased gradually decreased within 3 weeks(P<0.05). After treatment for 3 weeks, the observation group was compared with the control group, the differences of decrease in symptom score were significant(P<0.05). After treatment for 3 weeks, the total effective rates in the observation group and control group were 92.59%(50 /54) and 72.22%(39 /54), there were significant differences(P<0.05).Conclusion Composite curd capsules have faster efficacy in the treatment of infantile diarrhea, less side effects, and the clinical efficacy is certain. It has important clinical significance in improving the quality of life of children patients with diarrhea.%目的：探讨复合凝乳酶胶囊治疗小儿腹泻的临床效果。方法选取2012年3月～2013年4月收治的108例小儿腹泻患者，按照患儿入院先后顺序标号，偶数组作为观察组，奇数组作为对照组，每组54例。观察组患儿口服复合凝乳酶胶囊，对照组采用常规补液抗炎药物治疗，疗程为3周，每周对两组患儿进行随访，比较两组患者症状积分及治疗后的临床总有效率。结果两组治疗后症状积分均逐渐下降，3周末症状积分组内比较明显下降（P＜0.05）；治疗3周后，观察组症状积分下降与对照组比较，差异有统计学意义（P＜0.05）；3周后观察组与对照组临床总有效率分别为92.59%（50/54）、72.22%（39/54），两组比较差异有统计学意义（P＜0.05）。结论复合凝乳胶囊治疗小儿腹泻，临床疗效肯定。
展开▼
